Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Inge Henter

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
Nature Medicine|January 10, 2017
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignanciesNikolas Herold, Sean G Rudd, Linda Ljungblad, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
RMD Open|February 6, 2016
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
Transplantation and Cellular Therapy|October 9, 2025
Erratum to <Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome><[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>Melissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Transplantation and Cellular Therapy|March 11, 2023
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeMelissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Annals of the Rheumatic Diseases|February 12, 2016
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
Science Immunology|December 16, 2022
Notch-dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathologyEgle Kvedaraite, Paul Milne, Ahad Khalilnezhad, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2021
High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19Magda Lourda, Majda Dzidic, Laura Hertwig, et al.
Nature Communications|February 26, 2024
Intestinal stroma guides monocyte differentiation to macrophages through GM-CSFEgle Kvedaraite, Magda Lourda, Natalia Mouratidou, et al.
Hemasphere|June 9, 2026
Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for HistiocytosisFrancesco Pegoraro, Francois Chalard, Dmitry Evseev, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Nature Medicine|January 10, 2017
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignanciesNikolas Herold, Sean G Rudd, Linda Ljungblad, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
RMD Open|February 6, 2016
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
Transplantation and Cellular Therapy|October 9, 2025
Erratum to <Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome><[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>Melissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Transplantation and Cellular Therapy|March 11, 2023
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeMelissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Annals of the Rheumatic Diseases|February 12, 2016
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeAngelo Ravelli, Francesca Minoia, Sergio Davì, et al.
Science Immunology|December 16, 2022
Notch-dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathologyEgle Kvedaraite, Paul Milne, Ahad Khalilnezhad, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2021
High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19Magda Lourda, Majda Dzidic, Laura Hertwig, et al.
Nature Communications|February 26, 2024
Intestinal stroma guides monocyte differentiation to macrophages through GM-CSFEgle Kvedaraite, Magda Lourda, Natalia Mouratidou, et al.
Hemasphere|June 9, 2026
Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for HistiocytosisFrancesco Pegoraro, Francois Chalard, Dmitry Evseev, et al.
Pageof 21